Monograph
R01AA05 - Oxymetazoline |
Propably not porphyrinogenic |
PNP |
Rationale
Low dose, probably only insignificant systemic exposure.
Chemical description
Sympaticomimetic effective in high dilution (nasal drops/spray 0,25 mg/mL). Long duration of effect, needs only to be administered 2-3 times/24 h. No data on the extent of systemic absorbtion or metabolism.
IPNet drug reports
Uneventful use reported in 12 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025